To the full analysis
Buyback calculator for Akso Health Group
Akso Health Group stock: key metrics
AHGAkso Health Group had an operating margin of −28.9% and a return on invested capital (ROIC) of −3.1% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2015 | 65.4% | −6.4% | −7.5% |
| 2016 | 80.2% | 34.8% | 29.7% |
| 2017 | 77.5% | 43.3% | 37.4% |
| 2018 | 92.1% | 70.7% | 61.1% |
| 2019 | no data | no data | no data |
| 2020 | 100.0% | −695.7% | no data |
| 2021 | no data | no data | no data |
| 2022 | 10.1% | −54.3% | −280.8% |
| 2023 | 9.6% | −108.2% | no data |
| 2024 | no data | no data | no data |
| 2025 | −1.9% | −1,125.4% | −913.4% |
| 2026 | −0.1% | −28.9% | −135.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2015 | −10.5% | −9.8% | −4.7% |
| 2016 | 25.3% | 81.9% | 15.8% |
| 2017 | 36.5% | 160.9% | 30.2% |
| 2018 | 46.8% | 79.4% | 40.0% |
| 2019 | no data | −11.8% | no data |
| 2020 | no data | −50.2% | no data |
| 2021 | no data | −57.7% | no data |
| 2022 | −100.0% | −13.0% | −26.8% |
| 2023 | no data | no data | no data |
| 2024 | −6.8% | −25.2% | −6.7% |
| 2025 | −67.8% | −77.4% | −62.8% |
| 2026 | −10.3% | −3.1% | −9.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 8 Aug 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.